Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
The National Medical Products Administration (NMPA), the Chinese agency regulating drugs, may take a different view of ABL when it comes to CHF, and that can only benefit S Hepalink and indirectly Resverlogix. I believe S Hepalink's licence for ABL allows them to take it upon themselves to see this through.
